nodes	percent_of_prediction	percent_of_DWPC	metapath
Sitaxentan—CYP3A4—Budesonide—ulcerative colitis	0.07	0.122	CbGbCtD
Sitaxentan—CYP2C19—Nicotine—ulcerative colitis	0.063	0.109	CbGbCtD
Sitaxentan—CYP2C19—Cholecalciferol—ulcerative colitis	0.0565	0.0982	CbGbCtD
Sitaxentan—CYP2C9—Nicotine—ulcerative colitis	0.0524	0.091	CbGbCtD
Sitaxentan—CYP2C9—Cholecalciferol—ulcerative colitis	0.047	0.0816	CbGbCtD
Sitaxentan—CYP2C19—Prednisone—ulcerative colitis	0.0392	0.068	CbGbCtD
Sitaxentan—CYP3A4—Methylprednisolone—ulcerative colitis	0.0313	0.0543	CbGbCtD
Sitaxentan—CYP3A4—Nicotine—ulcerative colitis	0.0305	0.0529	CbGbCtD
Sitaxentan—CYP3A4—Cholecalciferol—ulcerative colitis	0.0273	0.0475	CbGbCtD
Sitaxentan—CYP2C19—Dexamethasone—ulcerative colitis	0.0245	0.0425	CbGbCtD
Sitaxentan—CYP3A4—Triamcinolone—ulcerative colitis	0.0237	0.0411	CbGbCtD
Sitaxentan—CYP2C9—Dexamethasone—ulcerative colitis	0.0203	0.0353	CbGbCtD
Sitaxentan—CYP3A4—Betamethasone—ulcerative colitis	0.0203	0.0353	CbGbCtD
Sitaxentan—CYP3A4—Prednisolone—ulcerative colitis	0.0201	0.0348	CbGbCtD
Sitaxentan—CYP3A4—Hydrocortisone—ulcerative colitis	0.019	0.033	CbGbCtD
Sitaxentan—CYP3A4—Prednisone—ulcerative colitis	0.0189	0.0329	CbGbCtD
Sitaxentan—CYP3A4—Dexamethasone—ulcerative colitis	0.0118	0.0205	CbGbCtD
Sitaxentan—EDNRB—Prostaglandin Synthesis and Regulation—PTGER4—ulcerative colitis	0.00353	0.0371	CbGpPWpGaD
Sitaxentan—EDNRB—Prostaglandin Synthesis and Regulation—PTGS1—ulcerative colitis	0.00347	0.0365	CbGpPWpGaD
Sitaxentan—EDNRB—GPCRs, Class A Rhodopsin-like—GPR35—ulcerative colitis	0.00272	0.0286	CbGpPWpGaD
Sitaxentan—EDNRB—Peptide GPCRs—CXCR1—ulcerative colitis	0.00265	0.0278	CbGpPWpGaD
Sitaxentan—EDNRA—Prostaglandin Synthesis and Regulation—PTGER4—ulcerative colitis	0.00253	0.0265	CbGpPWpGaD
Sitaxentan—EDNRA—Prostaglandin Synthesis and Regulation—PTGS1—ulcerative colitis	0.00249	0.0261	CbGpPWpGaD
Sitaxentan—EDNRB—Endothelins—GNA12—ulcerative colitis	0.00248	0.0261	CbGpPWpGaD
Sitaxentan—EDNRB—Peptide GPCRs—CXCR2—ulcerative colitis	0.00207	0.0218	CbGpPWpGaD
Sitaxentan—EDNRB—Peptide GPCRs—CCR6—ulcerative colitis	0.00195	0.0205	CbGpPWpGaD
Sitaxentan—EDNRA—GPCRs, Class A Rhodopsin-like—GPR35—ulcerative colitis	0.00194	0.0204	CbGpPWpGaD
Sitaxentan—EDNRA—Peptide GPCRs—CXCR1—ulcerative colitis	0.00189	0.0199	CbGpPWpGaD
Sitaxentan—EDNRA—Endothelins—GNA12—ulcerative colitis	0.00178	0.0187	CbGpPWpGaD
Sitaxentan—EDNRA—GPCRs, Other—CXCR1—ulcerative colitis	0.0016	0.0169	CbGpPWpGaD
Sitaxentan—EDNRA—Peptide GPCRs—CXCR2—ulcerative colitis	0.00148	0.0156	CbGpPWpGaD
Sitaxentan—EDNRA—Peptide GPCRs—CCR6—ulcerative colitis	0.00139	0.0146	CbGpPWpGaD
Sitaxentan—EDNRB—Prostaglandin Synthesis and Regulation—PTGS2—ulcerative colitis	0.00133	0.014	CbGpPWpGaD
Sitaxentan—EDNRA—GPCRs, Other—CXCR2—ulcerative colitis	0.00126	0.0132	CbGpPWpGaD
Sitaxentan—EDNRB—Endothelins—ADCY5—ulcerative colitis	0.00125	0.0132	CbGpPWpGaD
Sitaxentan—EDNRB—Peptide ligand-binding receptors—CXCR1—ulcerative colitis	0.00124	0.0131	CbGpPWpGaD
Sitaxentan—EDNRB—Endothelins—MMP1—ulcerative colitis	0.00111	0.0117	CbGpPWpGaD
Sitaxentan—EDNRB—Peptide ligand-binding receptors—CCL20—ulcerative colitis	0.00109	0.0115	CbGpPWpGaD
Sitaxentan—EDNRB—GPCRs, Class A Rhodopsin-like—CXCR1—ulcerative colitis	0.000974	0.0102	CbGpPWpGaD
Sitaxentan—EDNRB—Peptide ligand-binding receptors—CXCR2—ulcerative colitis	0.000974	0.0102	CbGpPWpGaD
Sitaxentan—EDNRA—Prostaglandin Synthesis and Regulation—PTGS2—ulcerative colitis	0.000953	0.01	CbGpPWpGaD
Sitaxentan—EDNRB—Peptide ligand-binding receptors—CCR6—ulcerative colitis	0.000915	0.00962	CbGpPWpGaD
Sitaxentan—EDNRA—Endothelins—ADCY5—ulcerative colitis	0.000897	0.00943	CbGpPWpGaD
Sitaxentan—EDNRA—Peptide ligand-binding receptors—CXCR1—ulcerative colitis	0.00089	0.00936	CbGpPWpGaD
Sitaxentan—EDNRB—Class A/1 (Rhodopsin-like receptors)—CXCR1—ulcerative colitis	0.000835	0.00877	CbGpPWpGaD
Sitaxentan—EDNRA—Endothelins—MMP1—ulcerative colitis	0.000794	0.00834	CbGpPWpGaD
Sitaxentan—EDNRA—GPCRs, Other—ADRB2—ulcerative colitis	0.000788	0.00828	CbGpPWpGaD
Sitaxentan—EDNRA—Peptide ligand-binding receptors—CCL20—ulcerative colitis	0.000782	0.00822	CbGpPWpGaD
Sitaxentan—EDNRB—Endothelins—JAK2—ulcerative colitis	0.000782	0.00821	CbGpPWpGaD
Sitaxentan—EDNRB—GPCRs, Class A Rhodopsin-like—CXCR2—ulcerative colitis	0.000762	0.00801	CbGpPWpGaD
Sitaxentan—EDNRB—G alpha (q) signalling events—GHRL—ulcerative colitis	0.000747	0.00785	CbGpPWpGaD
Sitaxentan—EDNRB—Peptide ligand-binding receptors—GHRL—ulcerative colitis	0.000738	0.00775	CbGpPWpGaD
Sitaxentan—EDNRB—Class A/1 (Rhodopsin-like receptors)—CCL20—ulcerative colitis	0.000733	0.0077	CbGpPWpGaD
Sitaxentan—EDNRB—GPCRs, Class A Rhodopsin-like—CCR6—ulcerative colitis	0.000717	0.00753	CbGpPWpGaD
Sitaxentan—CYP3A4—Codeine and Morphine Metabolism—ABCB1—ulcerative colitis	0.000711	0.00748	CbGpPWpGaD
Sitaxentan—EDNRA—GPCRs, Class A Rhodopsin-like—CXCR1—ulcerative colitis	0.000697	0.00733	CbGpPWpGaD
Sitaxentan—EDNRA—Peptide ligand-binding receptors—CXCR2—ulcerative colitis	0.000697	0.00732	CbGpPWpGaD
Sitaxentan—EDNRB—Gastrin-CREB signalling pathway via PKC and MAPK—GHRL—ulcerative colitis	0.000668	0.00702	CbGpPWpGaD
Sitaxentan—EDNRA—Peptide ligand-binding receptors—CCR6—ulcerative colitis	0.000655	0.00689	CbGpPWpGaD
Sitaxentan—EDNRB—Class A/1 (Rhodopsin-like receptors)—CXCR2—ulcerative colitis	0.000653	0.00686	CbGpPWpGaD
Sitaxentan—EDNRB—GPCR ligand binding—CXCR1—ulcerative colitis	0.000635	0.00668	CbGpPWpGaD
Sitaxentan—EDNRB—GPCRs, Class A Rhodopsin-like—PTGER4—ulcerative colitis	0.000631	0.00663	CbGpPWpGaD
Sitaxentan—EDNRB—Class A/1 (Rhodopsin-like receptors)—CCR6—ulcerative colitis	0.000614	0.00645	CbGpPWpGaD
Sitaxentan—EDNRA—Class A/1 (Rhodopsin-like receptors)—CXCR1—ulcerative colitis	0.000597	0.00628	CbGpPWpGaD
Sitaxentan—EDNRA—Endothelins—JAK2—ulcerative colitis	0.000559	0.00588	CbGpPWpGaD
Sitaxentan—EDNRB—GPCR ligand binding—CCL20—ulcerative colitis	0.000558	0.00586	CbGpPWpGaD
Sitaxentan—EDNRA—GPCRs, Class A Rhodopsin-like—CXCR2—ulcerative colitis	0.000545	0.00573	CbGpPWpGaD
Sitaxentan—EDNRB—Class A/1 (Rhodopsin-like receptors)—PTGER4—ulcerative colitis	0.000541	0.00568	CbGpPWpGaD
Sitaxentan—EDNRA—G alpha (q) signalling events—GHRL—ulcerative colitis	0.000535	0.00562	CbGpPWpGaD
Sitaxentan—EDNRA—Peptide ligand-binding receptors—GHRL—ulcerative colitis	0.000528	0.00555	CbGpPWpGaD
Sitaxentan—EDNRA—Class A/1 (Rhodopsin-like receptors)—CCL20—ulcerative colitis	0.000524	0.00551	CbGpPWpGaD
Sitaxentan—EDNRA—GPCRs, Class A Rhodopsin-like—CCR6—ulcerative colitis	0.000513	0.00539	CbGpPWpGaD
Sitaxentan—EDNRB—GPCR ligand binding—CXCR2—ulcerative colitis	0.000497	0.00523	CbGpPWpGaD
Sitaxentan—EDNRB—Class A/1 (Rhodopsin-like receptors)—GHRL—ulcerative colitis	0.000495	0.0052	CbGpPWpGaD
Sitaxentan—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—GHRL—ulcerative colitis	0.000478	0.00503	CbGpPWpGaD
Sitaxentan—EDNRB—GPCRs, Class A Rhodopsin-like—ADRB2—ulcerative colitis	0.000478	0.00503	CbGpPWpGaD
Sitaxentan—EDNRB—GPCR ligand binding—CCR6—ulcerative colitis	0.000468	0.00491	CbGpPWpGaD
Sitaxentan—EDNRA—Class A/1 (Rhodopsin-like receptors)—CXCR2—ulcerative colitis	0.000467	0.00491	CbGpPWpGaD
Sitaxentan—EDNRA—GPCR ligand binding—CXCR1—ulcerative colitis	0.000455	0.00478	CbGpPWpGaD
Sitaxentan—EDNRA—GPCRs, Class A Rhodopsin-like—PTGER4—ulcerative colitis	0.000452	0.00475	CbGpPWpGaD
Sitaxentan—EDNRA—Class A/1 (Rhodopsin-like receptors)—CCR6—ulcerative colitis	0.000439	0.00462	CbGpPWpGaD
Sitaxentan—EDNRB—GPCR ligand binding—PTGER4—ulcerative colitis	0.000412	0.00433	CbGpPWpGaD
Sitaxentan—EDNRB—Class A/1 (Rhodopsin-like receptors)—ADRB2—ulcerative colitis	0.00041	0.00431	CbGpPWpGaD
Sitaxentan—EDNRA—GPCR ligand binding—CCL20—ulcerative colitis	0.000399	0.0042	CbGpPWpGaD
Sitaxentan—CYP2C19—Constitutive Androstane Receptor Pathway—ABCB1—ulcerative colitis	0.00039	0.0041	CbGpPWpGaD
Sitaxentan—CYP2C19—Arachidonic acid metabolism—PTGS1—ulcerative colitis	0.00039	0.0041	CbGpPWpGaD
Sitaxentan—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—ulcerative colitis	0.000389	0.00409	CbGpPWpGaD
Sitaxentan—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—ulcerative colitis	0.000388	0.00408	CbGpPWpGaD
Sitaxentan—EDNRA—Class A/1 (Rhodopsin-like receptors)—PTGER4—ulcerative colitis	0.000387	0.00407	CbGpPWpGaD
Sitaxentan—EDNRB—GPCR ligand binding—GHRL—ulcerative colitis	0.000377	0.00396	CbGpPWpGaD
Sitaxentan—EDNRB—GPCR downstream signaling—CXCR1—ulcerative colitis	0.000359	0.00377	CbGpPWpGaD
Sitaxentan—EDNRA—GPCR ligand binding—CXCR2—ulcerative colitis	0.000356	0.00374	CbGpPWpGaD
Sitaxentan—CYP2C9—Constitutive Androstane Receptor Pathway—ABCB1—ulcerative colitis	0.000356	0.00374	CbGpPWpGaD
Sitaxentan—CYP2C9—Arachidonic acid metabolism—PTGS1—ulcerative colitis	0.000356	0.00374	CbGpPWpGaD
Sitaxentan—EDNRA—Class A/1 (Rhodopsin-like receptors)—GHRL—ulcerative colitis	0.000354	0.00372	CbGpPWpGaD
Sitaxentan—EDNRA—GPCRs, Class A Rhodopsin-like—ADRB2—ulcerative colitis	0.000342	0.0036	CbGpPWpGaD
Sitaxentan—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—ulcerative colitis	0.000339	0.00356	CbGpPWpGaD
Sitaxentan—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—ulcerative colitis	0.000338	0.00356	CbGpPWpGaD
Sitaxentan—EDNRA—GPCR ligand binding—CCR6—ulcerative colitis	0.000335	0.00352	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling by GPCR—CXCR1—ulcerative colitis	0.000326	0.00343	CbGpPWpGaD
Sitaxentan—EDNRB—GPCR downstream signaling—CCL20—ulcerative colitis	0.000315	0.00331	CbGpPWpGaD
Sitaxentan—EDNRB—GPCR ligand binding—ADRB2—ulcerative colitis	0.000312	0.00328	CbGpPWpGaD
Sitaxentan—EDNRB—GPCR downstream signaling—GNA12—ulcerative colitis	0.000296	0.00312	CbGpPWpGaD
Sitaxentan—EDNRB—Peptide ligand-binding receptors—CXCL8—ulcerative colitis	0.000295	0.0031	CbGpPWpGaD
Sitaxentan—EDNRA—GPCR ligand binding—PTGER4—ulcerative colitis	0.000295	0.0031	CbGpPWpGaD
Sitaxentan—EDNRA—Class A/1 (Rhodopsin-like receptors)—ADRB2—ulcerative colitis	0.000293	0.00308	CbGpPWpGaD
Sitaxentan—EDNRB—Gastrin-CREB signalling pathway via PKC and MAPK—JAK2—ulcerative colitis	0.000293	0.00308	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling by GPCR—CCL20—ulcerative colitis	0.000286	0.00301	CbGpPWpGaD
Sitaxentan—EDNRB—GPCR downstream signaling—CXCR2—ulcerative colitis	0.000281	0.00295	CbGpPWpGaD
Sitaxentan—CYP2C19—Phase 1 - Functionalization of compounds—PTGS1—ulcerative colitis	0.000273	0.00287	CbGpPWpGaD
Sitaxentan—EDNRA—GPCR ligand binding—GHRL—ulcerative colitis	0.00027	0.00283	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling by GPCR—GNA12—ulcerative colitis	0.000269	0.00283	CbGpPWpGaD
Sitaxentan—EDNRB—GPCR downstream signaling—CCR6—ulcerative colitis	0.000264	0.00278	CbGpPWpGaD
Sitaxentan—EDNRA—GPCR downstream signaling—CXCR1—ulcerative colitis	0.000257	0.0027	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling by GPCR—CXCR2—ulcerative colitis	0.000255	0.00268	CbGpPWpGaD
Sitaxentan—CYP2C9—Phase 1 - Functionalization of compounds—PTGS1—ulcerative colitis	0.000249	0.00262	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling by GPCR—CCR6—ulcerative colitis	0.00024	0.00252	CbGpPWpGaD
Sitaxentan—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—ulcerative colitis	0.000236	0.00248	CbGpPWpGaD
Sitaxentan—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—ulcerative colitis	0.000235	0.00247	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—SEL1L—ulcerative colitis	0.000234	0.00246	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling by GPCR—CXCR1—ulcerative colitis	0.000233	0.00245	CbGpPWpGaD
Sitaxentan—EDNRB—GPCR downstream signaling—PTGER4—ulcerative colitis	0.000233	0.00244	CbGpPWpGaD
Sitaxentan—EDNRA—GPCR downstream signaling—CCL20—ulcerative colitis	0.000226	0.00237	CbGpPWpGaD
Sitaxentan—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—ulcerative colitis	0.000224	0.00235	CbGpPWpGaD
Sitaxentan—EDNRA—GPCR ligand binding—ADRB2—ulcerative colitis	0.000223	0.00235	CbGpPWpGaD
Sitaxentan—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—ulcerative colitis	0.000223	0.00234	CbGpPWpGaD
Sitaxentan—EDNRB—GPCR downstream signaling—GHRL—ulcerative colitis	0.000213	0.00224	CbGpPWpGaD
Sitaxentan—EDNRA—GPCR downstream signaling—GNA12—ulcerative colitis	0.000212	0.00223	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling by GPCR—PTGER4—ulcerative colitis	0.000211	0.00222	CbGpPWpGaD
Sitaxentan—EDNRA—Peptide ligand-binding receptors—CXCL8—ulcerative colitis	0.000211	0.00222	CbGpPWpGaD
Sitaxentan—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—JAK2—ulcerative colitis	0.00021	0.0022	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling by GPCR—CCL20—ulcerative colitis	0.000205	0.00215	CbGpPWpGaD
Sitaxentan—EDNRA—GPCR downstream signaling—CXCR2—ulcerative colitis	0.000201	0.00211	CbGpPWpGaD
Sitaxentan—CYP2C19—Melatonin metabolism and effects—NFKB1—ulcerative colitis	0.000201	0.00211	CbGpPWpGaD
Sitaxentan—EDNRB—Class A/1 (Rhodopsin-like receptors)—CXCL8—ulcerative colitis	0.000198	0.00208	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling by GPCR—GHRL—ulcerative colitis	0.000193	0.00203	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling by GPCR—GNA12—ulcerative colitis	0.000193	0.00203	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—CXCR1—ulcerative colitis	0.000193	0.00202	CbGpPWpGaD
Sitaxentan—EDNRA—GPCR downstream signaling—CCR6—ulcerative colitis	0.000189	0.00199	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling by GPCR—CALM3—ulcerative colitis	0.000187	0.00197	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling by GPCR—CXCR2—ulcerative colitis	0.000183	0.00192	CbGpPWpGaD
Sitaxentan—EDNRB—GPCR downstream signaling—ADRB2—ulcerative colitis	0.000176	0.00185	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling by GPCR—CCR6—ulcerative colitis	0.000172	0.0018	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—CCL20—ulcerative colitis	0.000169	0.00178	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—SEL1L—ulcerative colitis	0.000167	0.00176	CbGpPWpGaD
Sitaxentan—EDNRA—GPCR downstream signaling—PTGER4—ulcerative colitis	0.000166	0.00175	CbGpPWpGaD
Sitaxentan—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—ulcerative colitis	0.000164	0.00173	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling by GPCR—ADRB2—ulcerative colitis	0.00016	0.00168	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—GNA12—ulcerative colitis	0.000159	0.00167	CbGpPWpGaD
Sitaxentan—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—ulcerative colitis	0.000156	0.00163	CbGpPWpGaD
Sitaxentan—EDNRA—GPCR downstream signaling—GHRL—ulcerative colitis	0.000152	0.0016	CbGpPWpGaD
Sitaxentan—Eye disorder—Methylprednisolone—ulcerative colitis	0.000152	0.000462	CcSEcCtD
Sitaxentan—Mental disorder—Hydrocortisone—ulcerative colitis	0.000152	0.000461	CcSEcCtD
Sitaxentan—EDNRA—Signaling by GPCR—PTGER4—ulcerative colitis	0.000151	0.00159	CbGpPWpGaD
Sitaxentan—Cardiac disorder—Methylprednisolone—ulcerative colitis	0.000151	0.000459	CcSEcCtD
Sitaxentan—Malnutrition—Hydrocortisone—ulcerative colitis	0.000151	0.000458	CcSEcCtD
Sitaxentan—EDNRB—Signaling Pathways—CXCR2—ulcerative colitis	0.000151	0.00158	CbGpPWpGaD
Sitaxentan—Bradycardia—Betamethasone—ulcerative colitis	0.000151	0.000458	CcSEcCtD
Sitaxentan—Bradycardia—Dexamethasone—ulcerative colitis	0.000151	0.000458	CcSEcCtD
Sitaxentan—EDNRB—GPCR ligand binding—CXCL8—ulcerative colitis	0.000151	0.00158	CbGpPWpGaD
Sitaxentan—Decreased appetite—Mesalazine—ulcerative colitis	0.000151	0.000457	CcSEcCtD
Sitaxentan—Body temperature increased—Azathioprine—ulcerative colitis	0.00015	0.000457	CcSEcCtD
Sitaxentan—EDNRB—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—ulcerative colitis	0.00015	0.00158	CbGpPWpGaD
Sitaxentan—EDNRB—GPCR downstream signaling—ADCY5—ulcerative colitis	0.00015	0.00157	CbGpPWpGaD
Sitaxentan—Gastrointestinal disorder—Mesalazine—ulcerative colitis	0.000149	0.000454	CcSEcCtD
Sitaxentan—CYP2C19—Arachidonic acid metabolism—PTGS2—ulcerative colitis	0.000149	0.00157	CbGpPWpGaD
Sitaxentan—Fatigue—Mesalazine—ulcerative colitis	0.000149	0.000454	CcSEcCtD
Sitaxentan—Haemoglobin—Betamethasone—ulcerative colitis	0.000149	0.000452	CcSEcCtD
Sitaxentan—Haemoglobin—Dexamethasone—ulcerative colitis	0.000149	0.000452	CcSEcCtD
Sitaxentan—Pain—Mesalazine—ulcerative colitis	0.000148	0.00045	CcSEcCtD
Sitaxentan—Constipation—Mesalazine—ulcerative colitis	0.000148	0.00045	CcSEcCtD
Sitaxentan—Haemorrhage—Dexamethasone—ulcerative colitis	0.000148	0.00045	CcSEcCtD
Sitaxentan—Haemorrhage—Betamethasone—ulcerative colitis	0.000148	0.00045	CcSEcCtD
Sitaxentan—Angiopathy—Methylprednisolone—ulcerative colitis	0.000148	0.000449	CcSEcCtD
Sitaxentan—Immune system disorder—Methylprednisolone—ulcerative colitis	0.000147	0.000447	CcSEcCtD
Sitaxentan—Mediastinal disorder—Methylprednisolone—ulcerative colitis	0.000147	0.000446	CcSEcCtD
Sitaxentan—Weight decreased—Prednisone—ulcerative colitis	0.000146	0.000443	CcSEcCtD
Sitaxentan—Diarrhoea—Budesonide—ulcerative colitis	0.000146	0.000443	CcSEcCtD
Sitaxentan—Hyperglycaemia—Prednisone—ulcerative colitis	0.000145	0.000442	CcSEcCtD
Sitaxentan—CYP2C19—Biological oxidations—PTGS1—ulcerative colitis	0.000145	0.00153	CbGpPWpGaD
Sitaxentan—Ill-defined disorder—Prednisolone—ulcerative colitis	0.000143	0.000436	CcSEcCtD
Sitaxentan—Visual impairment—Dexamethasone—ulcerative colitis	0.000143	0.000434	CcSEcCtD
Sitaxentan—Visual impairment—Betamethasone—ulcerative colitis	0.000143	0.000434	CcSEcCtD
Sitaxentan—Feeling abnormal—Mesalazine—ulcerative colitis	0.000143	0.000434	CcSEcCtD
Sitaxentan—Mental disorder—Methylprednisolone—ulcerative colitis	0.000143	0.000434	CcSEcCtD
Sitaxentan—EDNRB—Signaling Pathways—CCR6—ulcerative colitis	0.000142	0.00149	CbGpPWpGaD
Sitaxentan—Malnutrition—Methylprednisolone—ulcerative colitis	0.000142	0.000431	CcSEcCtD
Sitaxentan—EDNRA—Class A/1 (Rhodopsin-like receptors)—CXCL8—ulcerative colitis	0.000142	0.00149	CbGpPWpGaD
Sitaxentan—Acute coronary syndrome—Prednisone—ulcerative colitis	0.000142	0.00043	CcSEcCtD
Sitaxentan—Myocardial infarction—Prednisone—ulcerative colitis	0.000141	0.000428	CcSEcCtD
Sitaxentan—Dizziness—Budesonide—ulcerative colitis	0.000141	0.000428	CcSEcCtD
Sitaxentan—Hypersensitivity—Azathioprine—ulcerative colitis	0.00014	0.000426	CcSEcCtD
Sitaxentan—Ill-defined disorder—Hydrocortisone—ulcerative colitis	0.00014	0.000425	CcSEcCtD
Sitaxentan—Malaise—Prednisolone—ulcerative colitis	0.000139	0.000423	CcSEcCtD
Sitaxentan—Vertigo—Prednisolone—ulcerative colitis	0.000139	0.000422	CcSEcCtD
Sitaxentan—EDNRA—Signaling by GPCR—GHRL—ulcerative colitis	0.000138	0.00145	CbGpPWpGaD
Sitaxentan—Eye disorder—Betamethasone—ulcerative colitis	0.000138	0.000421	CcSEcCtD
Sitaxentan—Eye disorder—Dexamethasone—ulcerative colitis	0.000138	0.000421	CcSEcCtD
Sitaxentan—EDNRA—Signaling Pathways—CXCR1—ulcerative colitis	0.000138	0.00145	CbGpPWpGaD
Sitaxentan—Urticaria—Mesalazine—ulcerative colitis	0.000138	0.000418	CcSEcCtD
Sitaxentan—Body temperature increased—Mesalazine—ulcerative colitis	0.000137	0.000416	CcSEcCtD
Sitaxentan—CYP2C9—Arachidonic acid metabolism—PTGS2—ulcerative colitis	0.000136	0.00143	CbGpPWpGaD
Sitaxentan—Malaise—Hydrocortisone—ulcerative colitis	0.000136	0.000413	CcSEcCtD
Sitaxentan—EDNRB—Signaling by GPCR—ADCY5—ulcerative colitis	0.000136	0.00143	CbGpPWpGaD
Sitaxentan—Vertigo—Hydrocortisone—ulcerative colitis	0.000136	0.000412	CcSEcCtD
Sitaxentan—Vomiting—Budesonide—ulcerative colitis	0.000135	0.000411	CcSEcCtD
Sitaxentan—EDNRB—Signaling Pathways—MAML2—ulcerative colitis	0.000134	0.00141	CbGpPWpGaD
Sitaxentan—Angiopathy—Betamethasone—ulcerative colitis	0.000134	0.000408	CcSEcCtD
Sitaxentan—Angiopathy—Dexamethasone—ulcerative colitis	0.000134	0.000408	CcSEcCtD
Sitaxentan—Rash—Budesonide—ulcerative colitis	0.000134	0.000408	CcSEcCtD
Sitaxentan—Dermatitis—Budesonide—ulcerative colitis	0.000134	0.000408	CcSEcCtD
Sitaxentan—EDNRA—Signaling by GPCR—CALM3—ulcerative colitis	0.000134	0.00141	CbGpPWpGaD
Sitaxentan—Headache—Budesonide—ulcerative colitis	0.000133	0.000405	CcSEcCtD
Sitaxentan—CYP2C9—Biological oxidations—PTGS1—ulcerative colitis	0.000132	0.00139	CbGpPWpGaD
Sitaxentan—Ill-defined disorder—Triamcinolone—ulcerative colitis	0.000132	0.000401	CcSEcCtD
Sitaxentan—Ill-defined disorder—Methylprednisolone—ulcerative colitis	0.000132	0.0004	CcSEcCtD
Sitaxentan—Bradycardia—Prednisone—ulcerative colitis	0.000131	0.000399	CcSEcCtD
Sitaxentan—Alopecia—Dexamethasone—ulcerative colitis	0.000131	0.000398	CcSEcCtD
Sitaxentan—Alopecia—Betamethasone—ulcerative colitis	0.000131	0.000398	CcSEcCtD
Sitaxentan—Diarrhoea—Azathioprine—ulcerative colitis	0.00013	0.000395	CcSEcCtD
Sitaxentan—Discomfort—Prednisolone—ulcerative colitis	0.00013	0.000395	CcSEcCtD
Sitaxentan—Haemoglobin—Prednisone—ulcerative colitis	0.00013	0.000394	CcSEcCtD
Sitaxentan—Haemorrhage—Prednisone—ulcerative colitis	0.000129	0.000392	CcSEcCtD
Sitaxentan—Malaise—Triamcinolone—ulcerative colitis	0.000128	0.000389	CcSEcCtD
Sitaxentan—Malaise—Methylprednisolone—ulcerative colitis	0.000128	0.000388	CcSEcCtD
Sitaxentan—Vertigo—Triamcinolone—ulcerative colitis	0.000128	0.000388	CcSEcCtD
Sitaxentan—Hypersensitivity—Mesalazine—ulcerative colitis	0.000128	0.000388	CcSEcCtD
Sitaxentan—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—ulcerative colitis	0.000128	0.000388	CcSEcCtD
Sitaxentan—Vertigo—Methylprednisolone—ulcerative colitis	0.000127	0.000387	CcSEcCtD
Sitaxentan—Discomfort—Hydrocortisone—ulcerative colitis	0.000127	0.000386	CcSEcCtD
Sitaxentan—Nausea—Budesonide—ulcerative colitis	0.000126	0.000384	CcSEcCtD
Sitaxentan—EDNRA—GPCR downstream signaling—ADRB2—ulcerative colitis	0.000126	0.00133	CbGpPWpGaD
Sitaxentan—Oedema—Prednisolone—ulcerative colitis	0.000126	0.000383	CcSEcCtD
Sitaxentan—Dizziness—Azathioprine—ulcerative colitis	0.000126	0.000382	CcSEcCtD
Sitaxentan—EDNRB—Signaling Pathways—PTGER4—ulcerative colitis	0.000125	0.00131	CbGpPWpGaD
Sitaxentan—Asthenia—Mesalazine—ulcerative colitis	0.000124	0.000378	CcSEcCtD
Sitaxentan—Oedema—Hydrocortisone—ulcerative colitis	0.000123	0.000374	CcSEcCtD
Sitaxentan—Tachycardia—Prednisolone—ulcerative colitis	0.000123	0.000374	CcSEcCtD
Sitaxentan—Infection—Hydrocortisone—ulcerative colitis	0.000122	0.000372	CcSEcCtD
Sitaxentan—EDNRA—Signaling Pathways—CCL20—ulcerative colitis	0.000121	0.00127	CbGpPWpGaD
Sitaxentan—Vomiting—Azathioprine—ulcerative colitis	0.000121	0.000367	CcSEcCtD
Sitaxentan—Nervous system disorder—Hydrocortisone—ulcerative colitis	0.000121	0.000367	CcSEcCtD
Sitaxentan—Eye disorder—Prednisone—ulcerative colitis	0.000121	0.000366	CcSEcCtD
Sitaxentan—Tachycardia—Hydrocortisone—ulcerative colitis	0.00012	0.000365	CcSEcCtD
Sitaxentan—Rash—Azathioprine—ulcerative colitis	0.00012	0.000364	CcSEcCtD
Sitaxentan—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ulcerative colitis	0.00012	0.000364	CcSEcCtD
Sitaxentan—Dermatitis—Azathioprine—ulcerative colitis	0.00012	0.000364	CcSEcCtD
Sitaxentan—Flushing—Prednisone—ulcerative colitis	0.00012	0.000364	CcSEcCtD
Sitaxentan—Skin disorder—Hydrocortisone—ulcerative colitis	0.00012	0.000363	CcSEcCtD
Sitaxentan—Ill-defined disorder—Betamethasone—ulcerative colitis	0.00012	0.000363	CcSEcCtD
Sitaxentan—Ill-defined disorder—Dexamethasone—ulcerative colitis	0.00012	0.000363	CcSEcCtD
Sitaxentan—Discomfort—Triamcinolone—ulcerative colitis	0.000119	0.000363	CcSEcCtD
Sitaxentan—Discomfort—Methylprednisolone—ulcerative colitis	0.000119	0.000362	CcSEcCtD
Sitaxentan—Headache—Azathioprine—ulcerative colitis	0.000119	0.000362	CcSEcCtD
Sitaxentan—Diarrhoea—Mesalazine—ulcerative colitis	0.000118	0.00036	CcSEcCtD
Sitaxentan—Dry mouth—Triamcinolone—ulcerative colitis	0.000118	0.000359	CcSEcCtD
Sitaxentan—Anorexia—Hydrocortisone—ulcerative colitis	0.000117	0.000357	CcSEcCtD
Sitaxentan—Angiopathy—Prednisone—ulcerative colitis	0.000117	0.000356	CcSEcCtD
Sitaxentan—Confusional state—Methylprednisolone—ulcerative colitis	0.000117	0.000354	CcSEcCtD
Sitaxentan—Immune system disorder—Prednisone—ulcerative colitis	0.000116	0.000354	CcSEcCtD
Sitaxentan—Malaise—Betamethasone—ulcerative colitis	0.000116	0.000353	CcSEcCtD
Sitaxentan—Malaise—Dexamethasone—ulcerative colitis	0.000116	0.000353	CcSEcCtD
Sitaxentan—Oedema—Triamcinolone—ulcerative colitis	0.000116	0.000352	CcSEcCtD
Sitaxentan—Vertigo—Betamethasone—ulcerative colitis	0.000116	0.000352	CcSEcCtD
Sitaxentan—Vertigo—Dexamethasone—ulcerative colitis	0.000116	0.000352	CcSEcCtD
Sitaxentan—Infection—Triamcinolone—ulcerative colitis	0.000115	0.00035	CcSEcCtD
Sitaxentan—Hypotension—Hydrocortisone—ulcerative colitis	0.000115	0.00035	CcSEcCtD
Sitaxentan—Infection—Methylprednisolone—ulcerative colitis	0.000115	0.000349	CcSEcCtD
Sitaxentan—EDNRA—Signaling by GPCR—ADRB2—ulcerative colitis	0.000115	0.0012	CbGpPWpGaD
Sitaxentan—Dizziness—Mesalazine—ulcerative colitis	0.000114	0.000348	CcSEcCtD
Sitaxentan—EDNRB—Signaling Pathways—GHRL—ulcerative colitis	0.000114	0.0012	CbGpPWpGaD
Sitaxentan—Insomnia—Prednisolone—ulcerative colitis	0.000114	0.000347	CcSEcCtD
Sitaxentan—Alopecia—Prednisone—ulcerative colitis	0.000114	0.000346	CcSEcCtD
Sitaxentan—EDNRA—Signaling Pathways—GNA12—ulcerative colitis	0.000114	0.0012	CbGpPWpGaD
Sitaxentan—Nervous system disorder—Methylprednisolone—ulcerative colitis	0.000113	0.000345	CcSEcCtD
Sitaxentan—Tachycardia—Triamcinolone—ulcerative colitis	0.000113	0.000344	CcSEcCtD
Sitaxentan—Mental disorder—Prednisone—ulcerative colitis	0.000113	0.000343	CcSEcCtD
Sitaxentan—Nausea—Azathioprine—ulcerative colitis	0.000113	0.000343	CcSEcCtD
Sitaxentan—Tachycardia—Methylprednisolone—ulcerative colitis	0.000113	0.000343	CcSEcCtD
Sitaxentan—Skin disorder—Methylprednisolone—ulcerative colitis	0.000112	0.000341	CcSEcCtD
Sitaxentan—Malnutrition—Prednisone—ulcerative colitis	0.000112	0.000341	CcSEcCtD
Sitaxentan—Insomnia—Hydrocortisone—ulcerative colitis	0.000111	0.000338	CcSEcCtD
Sitaxentan—EDNRB—Signaling Pathways—CALM3—ulcerative colitis	0.000111	0.00116	CbGpPWpGaD
Sitaxentan—Vomiting—Mesalazine—ulcerative colitis	0.00011	0.000335	CcSEcCtD
Sitaxentan—Rash—Mesalazine—ulcerative colitis	0.000109	0.000332	CcSEcCtD
Sitaxentan—Dermatitis—Mesalazine—ulcerative colitis	0.000109	0.000331	CcSEcCtD
Sitaxentan—EDNRB—Signaling Pathways—RIPK2—ulcerative colitis	0.000109	0.00115	CbGpPWpGaD
Sitaxentan—Headache—Mesalazine—ulcerative colitis	0.000108	0.00033	CcSEcCtD
Sitaxentan—Discomfort—Betamethasone—ulcerative colitis	0.000108	0.000329	CcSEcCtD
Sitaxentan—Discomfort—Dexamethasone—ulcerative colitis	0.000108	0.000329	CcSEcCtD
Sitaxentan—Dyspepsia—Hydrocortisone—ulcerative colitis	0.000108	0.000329	CcSEcCtD
Sitaxentan—Hypotension—Methylprednisolone—ulcerative colitis	0.000108	0.000328	CcSEcCtD
Sitaxentan—EDNRA—Signaling Pathways—CXCR2—ulcerative colitis	0.000108	0.00113	CbGpPWpGaD
Sitaxentan—EDNRA—GPCR ligand binding—CXCL8—ulcerative colitis	0.000108	0.00113	CbGpPWpGaD
Sitaxentan—Pain—Prednisolone—ulcerative colitis	0.000108	0.000328	CcSEcCtD
Sitaxentan—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—ulcerative colitis	0.000107	0.00113	CbGpPWpGaD
Sitaxentan—EDNRA—GPCR downstream signaling—ADCY5—ulcerative colitis	0.000107	0.00113	CbGpPWpGaD
Sitaxentan—Decreased appetite—Hydrocortisone—ulcerative colitis	0.000107	0.000325	CcSEcCtD
Sitaxentan—Gastrointestinal disorder—Hydrocortisone—ulcerative colitis	0.000106	0.000323	CcSEcCtD
Sitaxentan—Fatigue—Hydrocortisone—ulcerative colitis	0.000106	0.000323	CcSEcCtD
Sitaxentan—Pain—Hydrocortisone—ulcerative colitis	0.000105	0.00032	CcSEcCtD
Sitaxentan—Oedema—Dexamethasone—ulcerative colitis	0.000105	0.00032	CcSEcCtD
Sitaxentan—Oedema—Betamethasone—ulcerative colitis	0.000105	0.00032	CcSEcCtD
Sitaxentan—Insomnia—Triamcinolone—ulcerative colitis	0.000105	0.000319	CcSEcCtD
Sitaxentan—Insomnia—Methylprednisolone—ulcerative colitis	0.000105	0.000318	CcSEcCtD
Sitaxentan—Infection—Dexamethasone—ulcerative colitis	0.000105	0.000318	CcSEcCtD
Sitaxentan—Infection—Betamethasone—ulcerative colitis	0.000105	0.000318	CcSEcCtD
Sitaxentan—Ill-defined disorder—Prednisone—ulcerative colitis	0.000104	0.000317	CcSEcCtD
Sitaxentan—Feeling abnormal—Prednisolone—ulcerative colitis	0.000104	0.000316	CcSEcCtD
Sitaxentan—Anaemia—Prednisone—ulcerative colitis	0.000104	0.000315	CcSEcCtD
Sitaxentan—Nervous system disorder—Dexamethasone—ulcerative colitis	0.000103	0.000314	CcSEcCtD
Sitaxentan—Nervous system disorder—Betamethasone—ulcerative colitis	0.000103	0.000314	CcSEcCtD
Sitaxentan—Agitation—Prednisone—ulcerative colitis	0.000103	0.000313	CcSEcCtD
Sitaxentan—Thrombocytopenia—Betamethasone—ulcerative colitis	0.000103	0.000313	CcSEcCtD
Sitaxentan—Thrombocytopenia—Dexamethasone—ulcerative colitis	0.000103	0.000313	CcSEcCtD
Sitaxentan—Nausea—Mesalazine—ulcerative colitis	0.000103	0.000313	CcSEcCtD
Sitaxentan—Tachycardia—Betamethasone—ulcerative colitis	0.000103	0.000312	CcSEcCtD
Sitaxentan—Tachycardia—Dexamethasone—ulcerative colitis	0.000103	0.000312	CcSEcCtD
Sitaxentan—Dyspepsia—Triamcinolone—ulcerative colitis	0.000102	0.00031	CcSEcCtD
Sitaxentan—Dyspepsia—Methylprednisolone—ulcerative colitis	0.000102	0.000309	CcSEcCtD
Sitaxentan—Feeling abnormal—Hydrocortisone—ulcerative colitis	0.000101	0.000308	CcSEcCtD
Sitaxentan—EDNRA—Signaling Pathways—CCR6—ulcerative colitis	0.000101	0.00107	CbGpPWpGaD
Sitaxentan—Malaise—Prednisone—ulcerative colitis	0.000101	0.000308	CcSEcCtD
Sitaxentan—Vertigo—Prednisone—ulcerative colitis	0.000101	0.000306	CcSEcCtD
Sitaxentan—Anorexia—Dexamethasone—ulcerative colitis	0.0001	0.000305	CcSEcCtD
Sitaxentan—Anorexia—Betamethasone—ulcerative colitis	0.0001	0.000305	CcSEcCtD
Sitaxentan—Urticaria—Prednisolone—ulcerative colitis	0.0001	0.000304	CcSEcCtD
Sitaxentan—Fatigue—Triamcinolone—ulcerative colitis	0.0001	0.000304	CcSEcCtD
Sitaxentan—Fatigue—Methylprednisolone—ulcerative colitis	9.97e-05	0.000303	CcSEcCtD
Sitaxentan—Pain—Triamcinolone—ulcerative colitis	9.91e-05	0.000301	CcSEcCtD
Sitaxentan—Hypotension—Dexamethasone—ulcerative colitis	9.83e-05	0.000299	CcSEcCtD
Sitaxentan—Hypotension—Betamethasone—ulcerative colitis	9.83e-05	0.000299	CcSEcCtD
Sitaxentan—Urticaria—Hydrocortisone—ulcerative colitis	9.78e-05	0.000297	CcSEcCtD
Sitaxentan—Body temperature increased—Hydrocortisone—ulcerative colitis	9.73e-05	0.000296	CcSEcCtD
Sitaxentan—EDNRA—Signaling by GPCR—ADCY5—ulcerative colitis	9.73e-05	0.00102	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—MAML2—ulcerative colitis	9.62e-05	0.00101	CbGpPWpGaD
Sitaxentan—Feeling abnormal—Triamcinolone—ulcerative colitis	9.55e-05	0.00029	CcSEcCtD
Sitaxentan—Feeling abnormal—Methylprednisolone—ulcerative colitis	9.53e-05	0.00029	CcSEcCtD
Sitaxentan—Insomnia—Betamethasone—ulcerative colitis	9.51e-05	0.000289	CcSEcCtD
Sitaxentan—Insomnia—Dexamethasone—ulcerative colitis	9.51e-05	0.000289	CcSEcCtD
Sitaxentan—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ulcerative colitis	9.49e-05	0.000288	CcSEcCtD
Sitaxentan—EDNRB—Signaling Pathways—ADRB2—ulcerative colitis	9.46e-05	0.000994	CbGpPWpGaD
Sitaxentan—Discomfort—Prednisone—ulcerative colitis	9.44e-05	0.000287	CcSEcCtD
Sitaxentan—EDNRB—GPCR downstream signaling—JAK2—ulcerative colitis	9.33e-05	0.000981	CbGpPWpGaD
Sitaxentan—Hypersensitivity—Prednisolone—ulcerative colitis	9.29e-05	0.000282	CcSEcCtD
Sitaxentan—Dyspepsia—Betamethasone—ulcerative colitis	9.26e-05	0.000281	CcSEcCtD
Sitaxentan—Dyspepsia—Dexamethasone—ulcerative colitis	9.26e-05	0.000281	CcSEcCtD
Sitaxentan—Urticaria—Triamcinolone—ulcerative colitis	9.21e-05	0.00028	CcSEcCtD
Sitaxentan—Urticaria—Methylprednisolone—ulcerative colitis	9.19e-05	0.000279	CcSEcCtD
Sitaxentan—Body temperature increased—Triamcinolone—ulcerative colitis	9.16e-05	0.000279	CcSEcCtD
Sitaxentan—Oedema—Prednisone—ulcerative colitis	9.16e-05	0.000278	CcSEcCtD
Sitaxentan—Decreased appetite—Dexamethasone—ulcerative colitis	9.14e-05	0.000278	CcSEcCtD
Sitaxentan—Decreased appetite—Betamethasone—ulcerative colitis	9.14e-05	0.000278	CcSEcCtD
Sitaxentan—Infection—Prednisone—ulcerative colitis	9.1e-05	0.000277	CcSEcCtD
Sitaxentan—Gastrointestinal disorder—Betamethasone—ulcerative colitis	9.08e-05	0.000276	CcSEcCtD
Sitaxentan—Gastrointestinal disorder—Dexamethasone—ulcerative colitis	9.08e-05	0.000276	CcSEcCtD
Sitaxentan—Hypersensitivity—Hydrocortisone—ulcerative colitis	9.07e-05	0.000276	CcSEcCtD
Sitaxentan—Fatigue—Dexamethasone—ulcerative colitis	9.07e-05	0.000276	CcSEcCtD
Sitaxentan—Fatigue—Betamethasone—ulcerative colitis	9.07e-05	0.000276	CcSEcCtD
Sitaxentan—Pain—Dexamethasone—ulcerative colitis	9e-05	0.000273	CcSEcCtD
Sitaxentan—Pain—Betamethasone—ulcerative colitis	9e-05	0.000273	CcSEcCtD
Sitaxentan—Nervous system disorder—Prednisone—ulcerative colitis	8.98e-05	0.000273	CcSEcCtD
Sitaxentan—Tachycardia—Prednisone—ulcerative colitis	8.94e-05	0.000272	CcSEcCtD
Sitaxentan—EDNRA—Signaling Pathways—PTGER4—ulcerative colitis	8.93e-05	0.000939	CbGpPWpGaD
Sitaxentan—Skin disorder—Prednisone—ulcerative colitis	8.9e-05	0.00027	CcSEcCtD
Sitaxentan—Asthenia—Hydrocortisone—ulcerative colitis	8.83e-05	0.000268	CcSEcCtD
Sitaxentan—Anorexia—Prednisone—ulcerative colitis	8.73e-05	0.000265	CcSEcCtD
Sitaxentan—CYP3A4—Biological oxidations—PTGS1—ulcerative colitis	8.73e-05	0.000917	CbGpPWpGaD
Sitaxentan—Feeling abnormal—Dexamethasone—ulcerative colitis	8.67e-05	0.000263	CcSEcCtD
Sitaxentan—Feeling abnormal—Betamethasone—ulcerative colitis	8.67e-05	0.000263	CcSEcCtD
Sitaxentan—Hypersensitivity—Triamcinolone—ulcerative colitis	8.54e-05	0.00026	CcSEcCtD
Sitaxentan—Hypersensitivity—Methylprednisolone—ulcerative colitis	8.52e-05	0.000259	CcSEcCtD
Sitaxentan—EDNRB—GPCR downstream signaling—CXCL8—ulcerative colitis	8.51e-05	0.000895	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling by GPCR—JAK2—ulcerative colitis	8.47e-05	0.00089	CbGpPWpGaD
Sitaxentan—Diarrhoea—Hydrocortisone—ulcerative colitis	8.42e-05	0.000256	CcSEcCtD
Sitaxentan—Urticaria—Betamethasone—ulcerative colitis	8.36e-05	0.000254	CcSEcCtD
Sitaxentan—Urticaria—Dexamethasone—ulcerative colitis	8.36e-05	0.000254	CcSEcCtD
Sitaxentan—Dizziness—Prednisolone—ulcerative colitis	8.34e-05	0.000253	CcSEcCtD
Sitaxentan—Asthenia—Triamcinolone—ulcerative colitis	8.32e-05	0.000253	CcSEcCtD
Sitaxentan—Body temperature increased—Betamethasone—ulcerative colitis	8.32e-05	0.000253	CcSEcCtD
Sitaxentan—Body temperature increased—Dexamethasone—ulcerative colitis	8.32e-05	0.000253	CcSEcCtD
Sitaxentan—Asthenia—Methylprednisolone—ulcerative colitis	8.3e-05	0.000252	CcSEcCtD
Sitaxentan—Insomnia—Prednisone—ulcerative colitis	8.29e-05	0.000252	CcSEcCtD
Sitaxentan—EDNRA—Signaling Pathways—GHRL—ulcerative colitis	8.18e-05	0.000859	CbGpPWpGaD
Sitaxentan—Dizziness—Hydrocortisone—ulcerative colitis	8.14e-05	0.000247	CcSEcCtD
Sitaxentan—EDNRB—GPCR downstream signaling—IL2—ulcerative colitis	8.14e-05	0.000855	CbGpPWpGaD
Sitaxentan—Dyspepsia—Prednisone—ulcerative colitis	8.06e-05	0.000245	CcSEcCtD
Sitaxentan—EDNRB—Signaling Pathways—ADCY5—ulcerative colitis	8.03e-05	0.000844	CbGpPWpGaD
Sitaxentan—Decreased appetite—Prednisone—ulcerative colitis	7.96e-05	0.000242	CcSEcCtD
Sitaxentan—Rash—Prednisolone—ulcerative colitis	7.95e-05	0.000242	CcSEcCtD
Sitaxentan—Dermatitis—Prednisolone—ulcerative colitis	7.94e-05	0.000241	CcSEcCtD
Sitaxentan—EDNRA—Signaling Pathways—CALM3—ulcerative colitis	7.92e-05	0.000832	CbGpPWpGaD
Sitaxentan—Diarrhoea—Methylprednisolone—ulcerative colitis	7.91e-05	0.000241	CcSEcCtD
Sitaxentan—Fatigue—Prednisone—ulcerative colitis	7.9e-05	0.00024	CcSEcCtD
Sitaxentan—Headache—Prednisolone—ulcerative colitis	7.9e-05	0.00024	CcSEcCtD
Sitaxentan—Constipation—Prednisone—ulcerative colitis	7.83e-05	0.000238	CcSEcCtD
Sitaxentan—Vomiting—Hydrocortisone—ulcerative colitis	7.83e-05	0.000238	CcSEcCtD
Sitaxentan—EDNRA—Signaling Pathways—RIPK2—ulcerative colitis	7.8e-05	0.00082	CbGpPWpGaD
Sitaxentan—Rash—Hydrocortisone—ulcerative colitis	7.76e-05	0.000236	CcSEcCtD
Sitaxentan—Dermatitis—Hydrocortisone—ulcerative colitis	7.76e-05	0.000236	CcSEcCtD
Sitaxentan—EDNRB—Signaling by GPCR—CXCL8—ulcerative colitis	7.73e-05	0.000813	CbGpPWpGaD
Sitaxentan—Headache—Hydrocortisone—ulcerative colitis	7.71e-05	0.000234	CcSEcCtD
Sitaxentan—Dizziness—Triamcinolone—ulcerative colitis	7.67e-05	0.000233	CcSEcCtD
Sitaxentan—Dizziness—Methylprednisolone—ulcerative colitis	7.65e-05	0.000232	CcSEcCtD
Sitaxentan—Feeling abnormal—Prednisone—ulcerative colitis	7.55e-05	0.000229	CcSEcCtD
Sitaxentan—Asthenia—Betamethasone—ulcerative colitis	7.55e-05	0.000229	CcSEcCtD
Sitaxentan—Asthenia—Dexamethasone—ulcerative colitis	7.55e-05	0.000229	CcSEcCtD
Sitaxentan—Nausea—Prednisolone—ulcerative colitis	7.49e-05	0.000228	CcSEcCtD
Sitaxentan—EDNRB—Signaling by GPCR—IL2—ulcerative colitis	7.39e-05	0.000777	CbGpPWpGaD
Sitaxentan—Vomiting—Triamcinolone—ulcerative colitis	7.37e-05	0.000224	CcSEcCtD
Sitaxentan—Vomiting—Methylprednisolone—ulcerative colitis	7.35e-05	0.000224	CcSEcCtD
Sitaxentan—Nausea—Hydrocortisone—ulcerative colitis	7.31e-05	0.000222	CcSEcCtD
Sitaxentan—Rash—Triamcinolone—ulcerative colitis	7.31e-05	0.000222	CcSEcCtD
Sitaxentan—Dermatitis—Triamcinolone—ulcerative colitis	7.3e-05	0.000222	CcSEcCtD
Sitaxentan—Rash—Methylprednisolone—ulcerative colitis	7.29e-05	0.000222	CcSEcCtD
Sitaxentan—Dermatitis—Methylprednisolone—ulcerative colitis	7.29e-05	0.000221	CcSEcCtD
Sitaxentan—Urticaria—Prednisone—ulcerative colitis	7.28e-05	0.000221	CcSEcCtD
Sitaxentan—Headache—Triamcinolone—ulcerative colitis	7.26e-05	0.000221	CcSEcCtD
Sitaxentan—Headache—Methylprednisolone—ulcerative colitis	7.25e-05	0.00022	CcSEcCtD
Sitaxentan—Body temperature increased—Prednisone—ulcerative colitis	7.24e-05	0.00022	CcSEcCtD
Sitaxentan—Diarrhoea—Dexamethasone—ulcerative colitis	7.2e-05	0.000219	CcSEcCtD
Sitaxentan—Diarrhoea—Betamethasone—ulcerative colitis	7.2e-05	0.000219	CcSEcCtD
Sitaxentan—Dizziness—Betamethasone—ulcerative colitis	6.96e-05	0.000211	CcSEcCtD
Sitaxentan—Dizziness—Dexamethasone—ulcerative colitis	6.96e-05	0.000211	CcSEcCtD
Sitaxentan—Nausea—Triamcinolone—ulcerative colitis	6.89e-05	0.000209	CcSEcCtD
Sitaxentan—Nausea—Methylprednisolone—ulcerative colitis	6.87e-05	0.000209	CcSEcCtD
Sitaxentan—EDNRA—Signaling Pathways—ADRB2—ulcerative colitis	6.77e-05	0.000711	CbGpPWpGaD
Sitaxentan—Hypersensitivity—Prednisone—ulcerative colitis	6.75e-05	0.000205	CcSEcCtD
Sitaxentan—Vomiting—Dexamethasone—ulcerative colitis	6.69e-05	0.000203	CcSEcCtD
Sitaxentan—Vomiting—Betamethasone—ulcerative colitis	6.69e-05	0.000203	CcSEcCtD
Sitaxentan—EDNRA—GPCR downstream signaling—JAK2—ulcerative colitis	6.68e-05	0.000702	CbGpPWpGaD
Sitaxentan—Rash—Dexamethasone—ulcerative colitis	6.63e-05	0.000202	CcSEcCtD
Sitaxentan—Rash—Betamethasone—ulcerative colitis	6.63e-05	0.000202	CcSEcCtD
Sitaxentan—Dermatitis—Dexamethasone—ulcerative colitis	6.63e-05	0.000201	CcSEcCtD
Sitaxentan—Dermatitis—Betamethasone—ulcerative colitis	6.63e-05	0.000201	CcSEcCtD
Sitaxentan—Headache—Dexamethasone—ulcerative colitis	6.59e-05	0.0002	CcSEcCtD
Sitaxentan—Headache—Betamethasone—ulcerative colitis	6.59e-05	0.0002	CcSEcCtD
Sitaxentan—Asthenia—Prednisone—ulcerative colitis	6.57e-05	0.0002	CcSEcCtD
Sitaxentan—Diarrhoea—Prednisone—ulcerative colitis	6.27e-05	0.00019	CcSEcCtD
Sitaxentan—Nausea—Dexamethasone—ulcerative colitis	6.25e-05	0.00019	CcSEcCtD
Sitaxentan—Nausea—Betamethasone—ulcerative colitis	6.25e-05	0.00019	CcSEcCtD
Sitaxentan—EDNRA—GPCR downstream signaling—CXCL8—ulcerative colitis	6.09e-05	0.00064	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling by GPCR—JAK2—ulcerative colitis	6.06e-05	0.000637	CbGpPWpGaD
Sitaxentan—Dizziness—Prednisone—ulcerative colitis	6.06e-05	0.000184	CcSEcCtD
Sitaxentan—CYP2C19—Metabolism—CHP1—ulcerative colitis	5.95e-05	0.000625	CbGpPWpGaD
Sitaxentan—Vomiting—Prednisone—ulcerative colitis	5.82e-05	0.000177	CcSEcCtD
Sitaxentan—EDNRA—GPCR downstream signaling—IL2—ulcerative colitis	5.82e-05	0.000612	CbGpPWpGaD
Sitaxentan—Rash—Prednisone—ulcerative colitis	5.78e-05	0.000176	CcSEcCtD
Sitaxentan—Dermatitis—Prednisone—ulcerative colitis	5.77e-05	0.000175	CcSEcCtD
Sitaxentan—EDNRA—Signaling Pathways—ADCY5—ulcerative colitis	5.75e-05	0.000604	CbGpPWpGaD
Sitaxentan—Headache—Prednisone—ulcerative colitis	5.74e-05	0.000174	CcSEcCtD
Sitaxentan—CYP2C19—Metabolism of lipids and lipoproteins—PTGS1—ulcerative colitis	5.57e-05	0.000586	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling by GPCR—CXCL8—ulcerative colitis	5.53e-05	0.000582	CbGpPWpGaD
Sitaxentan—Nausea—Prednisone—ulcerative colitis	5.44e-05	0.000165	CcSEcCtD
Sitaxentan—CYP2C9—Metabolism—CHP1—ulcerative colitis	5.42e-05	0.00057	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling by GPCR—IL2—ulcerative colitis	5.29e-05	0.000556	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—DLD—ulcerative colitis	5.13e-05	0.00054	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—ulcerative colitis	5.08e-05	0.000534	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—JAK2—ulcerative colitis	5e-05	0.000526	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—RELA—ulcerative colitis	4.85e-05	0.000509	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—DLD—ulcerative colitis	4.68e-05	0.000492	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—CXCL8—ulcerative colitis	4.57e-05	0.00048	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—IL2—ulcerative colitis	4.37e-05	0.000459	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling by GPCR—IL6—ulcerative colitis	4.34e-05	0.000456	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—MMP9—ulcerative colitis	4.13e-05	0.000434	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—NFKB1—ulcerative colitis	4.09e-05	0.00043	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—STAT3—ulcerative colitis	3.67e-05	0.000386	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—JAK2—ulcerative colitis	3.58e-05	0.000376	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—CHP1—ulcerative colitis	3.58e-05	0.000376	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—RELA—ulcerative colitis	3.47e-05	0.000365	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—TGFB1—ulcerative colitis	3.4e-05	0.000358	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—CXCL8—ulcerative colitis	3.27e-05	0.000344	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—IL2—ulcerative colitis	3.12e-05	0.000328	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling by GPCR—IL6—ulcerative colitis	3.11e-05	0.000327	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—DLD—ulcerative colitis	3.09e-05	0.000324	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—MMP9—ulcerative colitis	2.96e-05	0.000311	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—NFKB1—ulcerative colitis	2.93e-05	0.000307	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—TP53—ulcerative colitis	2.8e-05	0.000295	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	2.71e-05	0.000285	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—STAT3—ulcerative colitis	2.63e-05	0.000276	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—IL6—ulcerative colitis	2.57e-05	0.00027	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—PTGS1—ulcerative colitis	2.48e-05	0.000261	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	2.48e-05	0.00026	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	2.44e-05	0.000257	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—TGFB1—ulcerative colitis	2.44e-05	0.000256	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—PTGS1—ulcerative colitis	2.26e-05	0.000238	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—CALM3—ulcerative colitis	2.23e-05	0.000235	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	2.23e-05	0.000234	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	2.14e-05	0.000224	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—CALM3—ulcerative colitis	2.04e-05	0.000214	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—TP53—ulcerative colitis	2.01e-05	0.000211	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	1.95e-05	0.000205	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—IL6—ulcerative colitis	1.84e-05	0.000193	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—ABCB1—ulcerative colitis	1.74e-05	0.000183	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—ADCY5—ulcerative colitis	1.62e-05	0.00017	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—ABCB1—ulcerative colitis	1.58e-05	0.000167	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—PTGS1—ulcerative colitis	1.49e-05	0.000157	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—ADCY5—ulcerative colitis	1.48e-05	0.000155	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—CALM3—ulcerative colitis	1.34e-05	0.000141	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—PPARG—ulcerative colitis	1.21e-05	0.000127	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—PPARG—ulcerative colitis	1.1e-05	0.000116	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—ALB—ulcerative colitis	1.09e-05	0.000114	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—ABCB1—ulcerative colitis	1.05e-05	0.00011	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—ALB—ulcerative colitis	9.91e-06	0.000104	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—ADCY5—ulcerative colitis	9.75e-06	0.000102	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—PTGS2—ulcerative colitis	9.51e-06	0.0001	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—PTGS2—ulcerative colitis	8.67e-06	9.12e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—PPARG—ulcerative colitis	7.27e-06	7.64e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—ALB—ulcerative colitis	6.54e-06	6.87e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—PTGS2—ulcerative colitis	5.72e-06	6.01e-05	CbGpPWpGaD
